Interventions and decision-making at the end of life: the effect of establishing the terminal illness situation. See

Efficacy and safety evaluation of nilotinib and dasatinib (2G -TKI) on first line treatment in 73 patients with CML-CP outside of clinical trials. Andalusian CML registry (RALMC) See

Are the health messages in schoolbooks based on scientific evidence? A descriptive study. See

Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis. See